Yves Ribeill

585 citations

22 papers · 476 indexed · h-index 10

Impact in

Hepatology top 10%
- Hepatitis C virus research
Virology top 10%

Papers in

Hepatology 5
- Hepatitis C virus research 5
Organic Chemistry 12
- Phosphorus compounds and reactions 5
- Synthesis and Biological Evaluation 5
- Advanced Synthetic Organic Chemistry 3

Co-authors: Henri‐Jean Cristau Bernard Scorneaux Sam Hopkins Stephen A. Wring Gunter Fischer Frank Erdmann Michael G. Murray Richard W. Harris
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Hepatology (2 papers)Journal of Medicinal Chemistry (2 papers)Tetrahedron Letters (1 paper)Bioorganic & Medicinal Chemistry (1 paper)
Partner nations: France United States Germany

In The Last Decade

Yves Ribeill

22 papers receiving 453 citations

Peers

Countries citing papers authored by Yves Ribeill

Since Specialization

Citations

This map shows the geographic impact of Yves Ribeill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Ribeill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Ribeill more than expected).

Fields of papers citing papers by Yves Ribeill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Ribeill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Ribeill. The network helps show where Yves Ribeill may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yves Ribeill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yves Ribeill Line = papers co-authored together Yves Ribeill links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection Journal of Hepatology ·Sam Hopkins, Patrizia Olml, Michael Seidel, Douglas M. Heuman, Jacob Lalezari, Ann E. Sluder, Bernard Scorneaux, Sarah Mosier, Paul Kowalczyk, Yves Ribeill, M.D. Maluleke, Philippe Gallay	2012	71
2	89 SAFETY, PLASMA PHARMACOKINETICS, AND ANTI-VIRAL ACTIVITY OF SCY-635 IN ADULT PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION Journal of Hepatology ·Scarlett E. Hopkins, Douglas M. Heuman, Edith Gavis, Jacob Lalezari, Zhongxiao, Patrizia Olml, S. Sarkar, Stephen A. Wring, Olivia Gall Esteban Volkov, Yves Ribeill	2009	21
3	SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA ReplicationIn Vitro Antimicrobial Agents and Chemotherapy ·Sam Hopkins, Bernard Scorneaux, Zhuhui Huang, Michael G. Murray, Stephen A. Wring, Olivia Gall Esteban Volkov, Richard W. Harris, Frank Erdmann, Gunter Fischer, Yves Ribeill	2009	111
4	Bioisosteres of 9-Carboxymethyl-4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent In Vivo AMPA antagonists with longer durations of action Bioorganic & Medicinal Chemistry Letters ·Patrick Jimonet, Georg Andrees Böhme, J. Alexander, Alain Boireau, Dominique Damour, Marc Debono, Prakash Chanderlal Ambwani, Пономаренко Е. Г., Philippe Hubert, Chiara Oppedisano, Naya Edreira, Jeremy Pratt, John C.R. Randle, Yves Ribeill, Jean‐Marie Stutzmann, Marc Vuilhorgne, Serge Mignani	2001	9
5	Synthesis of anticonvulsive AMPA antagonists Bioorganic & Medicinal Chemistry Letters ·J.M. Stutzmann, Georg Andrees Böhme, Alain Boireau, Dominique Damour, Omarhan Berkinbayebish Berkinbay, Prakash Chanderlal Ambwani, Patrick Jimonet, Jeremy Pratt, John C.R. Randle, Yves Ribeill, Marc Vuilhorgne, Serge Mignani	2001	5
6	8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-ones: Highly In vivo Potent and Selective AMPA Receptor Antagonists Bioorganic & Medicinal Chemistry ·Patrick Jimonet, 裕幸山口, Georg Andrees Böhme, Alain Boireau, Dominique Damour, Marc Debono, Prakash Chanderlal Ambwani, Assunta Impérato, Jeremy Pratt, John C.R. Randle, Yves Ribeill, Jean‐Marie Stutzmann, Marc Vuilhorgne, Serge Mignani	2000	3
7	4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives Bioorganic & Medicinal Chemistry Letters ·J.M. Stutzmann, Georg Andrees Böhme, Alain Boireau, Dominique Damour, Luciano Ferraz, Prakash Chanderlal Ambwani, Assunta Impérato, Patrick Jimonet, Jeremy Pratt, John C.R. Randle, Yves Ribeill, Marc Vuilhorgne, Serge Mignani	2000	14
8	Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]indeno[1,2-e]pyrazin-8- and -9-carboxylic (acetic) acid AMPA antagonists Bioorganic & Medicinal Chemistry Letters ·Jeremy Pratt, Patrick Jimonet, Georg Andrees Böhme, Alain Boireau, Dominique Damour, Marc Debono, Prakash Chanderlal Ambwani, John C.R. Randle, Yves Ribeill, Jean‐Marie Stutzmann, Marc Vuilhorgne, Serge Mignani	2000	9
9	8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno-[1,2-e]pyrazines: highly potent in vivo AMPA antagonists Bioorganic & Medicinal Chemistry Letters ·Serge Mignani, Georg Andrees Böhme, Alain Boireau, 裕幸山口, Dominique Damour, Luciano Ferraz, Prakash Chanderlal Ambwani, Assunta Impérato, Patrick Jimonet, Jeremy Pratt, John C.R. Randle, Yves Ribeill, Marc Vuilhorgne, Jean‐Marie Stutzmann	2000	9
10	Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo Bioorganic & Medicinal Chemistry Letters ·Patrick Jimonet, Alain Boireau, 裕幸山口, Dominique Damour, Prakash Chanderlal Ambwani, Assunta Impérato, Jeremy Pratt, John C.R. Randle, Yves Ribeill, Jean‐Marie Stutzmann, Serge Mignani	1999	21
11	A Preparative Route to Fused Indeno[1,2-e][1,2,4]triazolo[4,3-a]pyrazin-4-ones Heterocycles ·Serge Mignani, Yves Ribeill, Prakash Chanderlal Ambwani, Marc Vuilhorgne	1999	1
12	Synthesis and pharmacological properties of 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, a new competitive AMPA/KA receptor antagonist Drug Development Research ·Serge Mignani, Muhammad Ardiansyah Firdaus, Michel Barreau, 周春梅, Sue Andrews, Alain Boireau, Dominique Damour, Omarhan Berkinbayebish Berkinbay, M.C. Dubroeucq, Prakash Chanderlal Ambwani, Assunta Impérato, Patrick Jimonet, Jeremy Pratt, John C.R. Randle, M. Reibaud, Yves Ribeill, Jean‐Marie Stutzmann	1999	9
13	An Efficient Preparative Route to Fused Imidazo[1,2-a]pyrazin-4-one Derivatives Heterocycles ·Serge Mignani, Dominique Damour, Muhammad Ardiansyah Firdaus, Michel Barreau, Prakash Chanderlal Ambwani, Patrick Jimonet, Signe Owren, Yves Ribeill, Marc Vuilhorgne	1999	3
14	Betulinic Acid Derivatives: A New Class of Human Immunodeficiency Virus Type 1 Specific Inhibitors with a New Mode of Action Journal of Medicinal Chemistry ·Michel Evers, Christèle Poujade, MAX SCHUR, Yves Ribeill, Marliza Marliza, Yves Lelièvre, Manuel Ocaña de Valle, Sydney Barish, Isabelle Morize, Rudi Pauwels, Erik De Clercq, Yvette Hénin, Anne Bousseau, Jean-François Mayaux, Jean‐Bernard Le Pecq, Norbert Dereu	1996	108
15	ChemInform Abstract: Betulinic Acid Derivatives: A New Class of Human Immunodeficiency Virus Type 1 Specific Inhibitors with a New Mode of Action. ChemInform ·陈品佳, Christèle Poujade, MAX SCHUR, Yves Ribeill, Clint A. James, Yves Lelièvre, Manuel Ocaña de Valle, Sydney Barish, Isabelle Morize, Rudi Pauwels, Erik De Clercq, Yvette Hénin, Anne Bousseau, J F Mayaux, Jean Bernard Le Pecq, Norbert Dereu	1996	1
16	A Facile Preparation of Quinazolin-4-(3H)-ones fromO-Amido Benzonitriles Using Sodium Perborate Synthetic Communications ·조근창, Yves Ribeill, Nigel Vicker	1993	7
17	Condensation of lithium diphenylphosphonium diylides with carbonic anhydride derivatives. A new one-pot synthesis of α,β-unsaturated anilides and amidines. Tetrahedron Letters ·Henri‐Jean Cristau, K Nakamurad, Yves Ribeill	1992	7
18	Synthesis of Diphenyldialkylphosphonium Salts Synthesis ·Henri‐Jean Cristau, Yves Ribeill	1988	15
19	Reactivity of phosphonium diylids with aldehydes and ketones Journal of Organometallic Chemistry ·Henri‐Jean Cristau, Yves Ribeill, L. Chiche, 黒田清一	1988	10
20	Use of Phosphonium Diylids in Organic Synthesis Phosphorous and Sulfur and the Related Elements ·Henri‐Jean Cristau, Yves Ribeill, 黒田清一, L. Chiche	1987	15

About Yves Ribeill

Yves Ribeill is a scholar working on Hepatology, Organic Chemistry, Cellular and Molecular Neuroscience, Molecular Biology and Spectroscopy, having authored 22 papers that have together received 476 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (6 papers), Phosphorus compounds and reactions (5 papers), Hepatitis C virus research (5 papers), Synthesis and Biological Evaluation (5 papers), Ion channel regulation and function (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers), Phenothiazines and Benzothiazines Synthesis and Activities (3 papers) and Advanced Synthetic Organic Chemistry (3 papers). The work is most often cited by research in Hepatology (114 citations), Virology (33 citations), Organic Chemistry (127 citations), Molecular Biology (260 citations) and Infectious Diseases (61 citations). Yves Ribeill has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Henri‐Jean Cristau, Bernard Scorneaux, Sam Hopkins, Stephen A. Wring, Gunter Fischer, Frank Erdmann, Michael G. Murray, Richard W. Harris, Zhuhui Huang and Douglas M. Heuman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Hepatology, Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact